Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
WY-14643: PPARα Control of Liver Pyroptosis
2026-09-10
WY-14643 (Pirinixic Acid) is examined here as a mechanistic tool for connecting PPARα activation with hepatic lipid regulation, inflammation, and pyroptosis. The article translates recent cholestatic liver injury findings into practical assay-design decisions while distinguishing class-level evidence from compound-specific conclusions.
Renal Blood Flow and K⁺ Channels in Septic Rats
2026-09-10
This study used complementary perfused-kidney and in vivo experiments to determine how potassium-channel blockade alters renal vascular responses to norepinephrine and phenylephrine during experimental sepsis. Its main contribution is showing that channel blockade can worsen renal hypoperfusion when combined with vasoactive drugs, even when the blockers alone do not change baseline renal blood flow.
Ceramides Drive RGNNV Infection Through Autophagy
2026-09-09
This study uses global lipidomics and pathway perturbation to show that red-spotted grouper nervous necrosis virus reshapes ceramide metabolism to support replication. Its most important mechanistic finding is that C16-ceramide promotes viral infection partly by enhancing virus-induced autophagy, identifying sphingolipid flux as a potential target for aquaculture virology.
Plerixafor: Reframing CXCR4 in Tumor Trafficking
2026-09-09
Plerixafor (AMD3100) is more than a stem cell mobilization reagent: it is a strategic probe for CXCL12/CXCR4-dependent trafficking across tumor, hematopoietic, and inflammatory systems. This article connects platelet extravasation biology with translational experimental design, competitive positioning, and practical workflows.
Zoledronic Acid: From Mechanism to Assay Design
2026-09-08
Zoledronic Acid is a nitrogen-containing bisphosphonate used in cancer and bone-disease research. This guide develops a decision-oriented assay framework, using a mechanistic psoriasis study to show how orthogonal validation can improve interpretation without conflating distinct biological systems.
Carbohydrate-Decorated Nanoparticles for Macrophage Therapy
2026-09-08
Chen and colleagues developed biodegradable nanoparticles that combine a cationic lipid-like component with carbohydrate-decorated PLGA or PLGA-PEG to improve gene delivery to macrophages. Their comparison of mannose, galactose, dextran, and mixed carbohydrate surfaces shows that nanoparticle composition influences uptake, reporter expression, and the practical performance of macrophage-targeted gene delivery.
Dabigatran Assays for Thrombin and CVD Research
2026-09-07
Dabigatran enables controlled, reversible thrombin inhibition across thrombin-generation, TT, aPTT, and PT workflows. This guide connects practical assay design with cardio-cerebrovascular research while addressing formulation, metabolite, and pathway-specific troubleshooting.
Matrine, YTHDF1, and Thymoma Stemness
2026-09-07
A 2026 study reports that Matrine reduces stemness-associated behavior and promotes apoptosis in EL-4-B5 thymoma cells, with YTHDF1 and Wnt/β-catenin signaling emerging as candidate mediators. The findings establish a useful in vitro framework for studying thymoma stemness, but the absence of direct m6A measurements, animal experiments, and clinical validation limits mechanistic and translational conclusions.
Jasplakinolide: Designing Better Actin Assays
2026-09-05
Jasplakinolide is a potent actin polymerization inducer and F-actin stabilizer for mechanistic cell biology. This guide explains how to convert its direct cytoskeletal activity into better-controlled assays, using chemical-genetic reasoning from jasmonate research to improve interpretation without conflating distinct pathways.
(-)-JQ1 in Heterogeneous BET Assays
2026-09-04
(-)-JQ1 is more than an inactive control: this JQ1 stereoisomer helps separate stereospecific BET biology from cell-line-specific stress responses. Learn how to apply it to HPV-associated cancer biology and BRD4 target gene modulation.
Gamma-linolenic acid: Applied Research Workflows
2026-09-04
Use Gamma-linolenic acid (GLA) to interrogate LTB4-linked inflammation, cellular stress, and apoptosis with controlled, solvent-aware workflows. A practical comparison with arachidonic acid research helps distinguish established anti-inflammatory applications from emerging nutritional-immunology questions.
KU-55933 and the Next Era of ATM Biology
2026-09-03
KU-55933 offers translational researchers a selective way to interrogate ATM signaling, linking DNA damage response research with Akt regulation, cell-cycle control, and cancer biology. This thought-leadership perspective places the compound alongside emerging telomere–mitochondrial findings while clearly separating established evidence from forward-looking hypotheses.
POx Lipids as PEG Alternatives for mRNA LNPs
2026-09-03
Holick and colleagues investigate poly(2-ethyl-2-oxazoline)-based lipids as tunable substitutes for PEG-lipids in mRNA lipid nanoparticles. By combining polymer synthesis, particle characterization, immunoreaction and transfection assays, and super-resolution microscopy, the study identifies a PEtOx-LNP formulation that outperformed the tested commercial PEG-lipid comparator and clarifies why chain length matters.
Antiarrhythmic Drugs at Cardiac KCa2 Channels
2026-09-02
This 2017 study used automated whole-cell patch clamp to test whether clinically used antiarrhythmic drugs inhibit human KCa2.2 and KCa2.3 channels, atrial-enriched targets proposed for atrial fibrillation therapy. Only dofetilide and propafenone showed measurable inhibition, and their relatively high IC50 values argue against a major contribution of KCa2 block at therapeutic free plasma concentrations.
Boc-D-FMK: From Caspase Blockade to Translation
2026-09-02
Boc-D-FMK is best positioned as a causal research tool: a cell-permeable pan-caspase inhibitor that helps translational scientists distinguish caspase-dependent apoptosis from persistent inflammatory and fibrotic signaling.
8193 records 7/547 page Previous Next First page 上5页 678910 下5页 Last page